
News|Videos|October 26, 2023
ASCENT Study: Impact of Sacituzumab Govitecan on Metastatic TNBC
Author(s)Nour Abuhadra, MD
Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into the positive outcomes from the ASCENT study.
Advertisement
Episodes in this series

Advertisement
Related to this article

Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the gratitude of living beyond cancer.

In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the screening visit, but its 24% lower rate of cancers found between screenings was not statistically significant.

Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed her care.

Debbie Legault, whose daughter was diagnosed with breast cancer at 27, urges shoppers to skip pink ribbon products and donate directly to support organizations.

Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.

Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.

In the phase 3 RT CHARM trial, published Oct. 12, 2026, in the Journal of Clinical Oncology, a three-week course of radiation after mastectomy caused about the same rate of reconstruction complications as the standard five-week course in women with breast cancer.
Advertisement
Advertisement
Trending on CURE
1
Diagnosed With Sarcoma at 21, She Found Her People at Mary's Place
2
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
3
How a Cancer Survivor Learned to Stop Hiding His Surgical Scars
4
Stage 4 Breast Cancer: How a Second Opinion Saved Her Life
5



